A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2001
10/24/2001	EP1147776A2 Use of botulinum toxin type B for the manufacture of a medicament for the treatment of muscle spasms
10/24/2001	EP1147775A2 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder
10/24/2001	EP1147413A2 Growth differentiation factor inhibitors and uses therefor
10/24/2001	EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001	EP1147121A2 Ketolide antibiotics
10/24/2001	EP1147119A1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
10/24/2001	EP1147116A1 Boron steroid mimics and pharmaceutical compositions
10/24/2001	EP1147110A1 Pyrazino(aza)indole derivatives
10/24/2001	EP1147103A1 Phenantrhridine-n-oxides with pde-iv inhibiting activity
10/24/2001	EP1147097A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/24/2001	EP1147092A1 Substituted imidazoles, their preparation and use
10/24/2001	EP1147091A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/24/2001	EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity
10/24/2001	EP1147088A1 6-arylphenanthridines with pde-iv inhibiting activity
10/24/2001	EP1147087A1 Phenanthridine-n-oxides with pde-iv inhibiting activity
10/24/2001	EP1146889A2 Identification of specific differentially expressed mycobacterial antigens
10/24/2001	EP1146888A2 Specific therapeutic interventions obtained by interference with redistribution and/or targetting
10/24/2001	EP1146883A1 Modulation of immune response by ribavirin
10/24/2001	EP1146876A2 Compositions having improved stability
10/24/2001	EP1146874A1 Vitronectin receptor antagonist
10/24/2001	EP1146868A1 Anti-inflammatory agents
10/24/2001	EP1146790A1 Compounds and methods
10/24/2001	EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/24/2001	EP0705099B1 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
10/24/2001	CN1319139A Polynucleotide constructs and uses thereof
10/24/2001	CN1319133A Short peptides which selectively modulate activity of protein kinases
10/24/2001	CN1319096A Quinazoline derivatives and pharmaceutical applications thereof
10/24/2001	CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001	CN1073557C Vitamin-D amide derivatives
10/24/2001	CN1073439C Medicine for treating tracheitis and asthma and its preparation
10/24/2001	CN1073435C Infantile cough plaster and its production method
10/23/2001	US6307060 Antispasmodic agents
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6307022 Def
10/23/2001	US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001	US6306886 Solid polymorph anticoagulants
10/23/2001	US6306883 Compounds
10/23/2001	US6306881 Anti-inflammatory agents
10/23/2001	US6306879 Isotonic glucose solution
10/23/2001	US6306876 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives
10/23/2001	US6306873 Substituted β-thiocarboxylic acids
10/23/2001	US6306869 N-oxides
10/23/2001	US6306867 Treatment of respiratory system disorders, tumor necrosis factor and leukotrienes
10/23/2001	US6306863 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
10/23/2001	US6306852 Indole derivatives useful as endothelin receptor antagonists
10/23/2001	US6306840 Cell adhesion inhibitors
10/23/2001	US6306612 Methods of facilitating vascular growth
10/23/2001	US6306429 Throat drops suitable for relief of cough and cold symptoms
10/23/2001	US6306369 Comprising bronchodilatory agent, anti-infalmmatory agent and 1,1,1,2-tetrafluoroethane propellent; for administration of medicaments by inhalation; for therapy of respiratory system disorders
10/23/2001	CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
10/23/2001	CA2035499C Substituted triazolopyridazines
10/18/2001	WO2001077378A2 Diagnosis of diseases associated with dna adducts
10/18/2001	WO2001077377A2 Diagnosis of diseases associated with dna replication by assessing dna methylation
10/18/2001	WO2001077376A2 Diagnosis of diseases associated with metastasis
10/18/2001	WO2001077375A2 Diagnosis of diseases associated with gene regulation
10/18/2001	WO2001077325A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001	WO2001077322A1 Cryptic-like secreted protein
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077164A2 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
10/18/2001	WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077110A1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
10/18/2001	WO2001077104A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
10/18/2001	WO2001077101A1 Chemical compounds
10/18/2001	WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists
10/18/2001	WO2001077093A1 Estrogen agonist/antagonist metabolites
10/18/2001	WO2001077092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/18/2001	WO2001077087A1 Novel compounds
10/18/2001	WO2001077069A1 Naphthamide neurokinin antagonists for use as medicaments
10/18/2001	WO2001076619A1 Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
10/18/2001	WO2001076607A1 Dry syrup containing theophylline sustained release microcapsules
10/18/2001	WO2001076601A2 Pharmaceutical compositions comprising salmeterol and ipratropium
10/18/2001	WO2001076600A2 Inhibition of cytokine generation
10/18/2001	WO2001076585A2 Use of thiamphenicol for the treatment of chlamydia pneumoniae infections
10/18/2001	WO2001076575A2 The treatment of respiratory diseases
10/18/2001	WO2001076572A2 Use of compatible solutes as substances having free radical scavenging properties
10/18/2001	WO2001076568A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/18/2001	WO2001076530A2 Il-8 receptor antagonists
10/18/2001	WO2001076451A2 Diagnosis of diseases associated with metabolism
10/18/2001	WO2001023388A3 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES
10/18/2001	WO2000043026A3 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation
10/18/2001	US20010031895 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines
10/18/2001	US20010031882 Lipoxin compounds and their use in treating cell proliferative disorders
10/18/2001	US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue
10/18/2001	US20010031777 Heterocyclic compounds and their therapeutic use
10/18/2001	US20010031766 Prostaglandin receptor ligands
10/18/2001	US20010031763 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents
10/18/2001	US20010031740 Mixture containing organic halide
10/18/2001	US20010031260 Administering tumor necrosis factor antagonist; rheumatic diseases, skin disorders
10/18/2001	DE10013782A1 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln 4-fluoroalkyl-2H-benzopyrans with antiestrogenic action, processes for their preparation, pharmaceutical compositions containing them and their use for the preparation of medicaments
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405800A1 Novel secreted protein
10/18/2001	CA2405413A1 Inhibition of cytokine generation
10/18/2001	CA2405089A1 Benzoamide piperidine containing compounds and related compounds
10/18/2001	CA2405070A1 Estrogen agonist/antagonist metabolites
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2403012A1 Chemical compounds
10/18/2001	CA2401290A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001	CA2372352A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
10/17/2001	EP1144648A1 Cyclic nucleotide-associated proteins

1 ... 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 ... 878